My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 506

    1.

    Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

    Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

    Diabetes Care. 2001 Apr;24(4):631-6.PMID: 11315821 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

    Yki-Järvinen H, Dressler A, Ziemen M; HOE 901/300s Study Group.

    Diabetes Care. 2000 Aug;23(8):1130-6.PMID: 10937510 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    4.

    Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

    Rosenstock J, Park G, Zimmerman J; U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

    Diabetes Care. 2000 Aug;23(8):1137-42.PMID: 10937511 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

    Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T.

    Diabetes Care. 2000 Nov;23(11):1666-71.PMID: 11092290 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

    Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA.

    Diabetes Care. 2000 May;23(5):639-43.PMID: 10834423 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

    Clin Ther. 2008 Nov;30(11):1976-87.PMID: 19108786 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

    Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

    Diabetes Care. 2003 May;26(5):1490-6.PMID: 12716810 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin glargine: a systematic review of a long-acting insulin analogue.

    Wang F, Carabino JM, Vergara CM.

    Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.PMID: 12860485 [PubMed - indexed for MEDLINE]Related articles

    10.

    Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

    Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU.

    Clin Ther. 2007 Aug;29(8):1607-19.PMID: 17919543 [PubMed - indexed for MEDLINE]Related articles

    11.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.

    Fritsche A, Schweitzer MA, Häring HU; 4001 Study Group.

    Ann Intern Med. 2003 Jun 17;138(12):952-9.PMID: 12809451 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study.

    Fonseca V, Bell DS, Berger S, Thomson S, Mecca TE.

    Am J Med Sci. 2004 Nov;328(5):274-80.PMID: 15545844 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

    Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A.

    Diabetes Care. 2005 Apr;28(4):950-5.PMID: 15793205 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

    Fulcher GR, Gilbert RE, Yue DK.

    Intern Med J. 2005 Sep;35(9):536-42.PMID: 16105155 [PubMed - indexed for MEDLINE]Related articles

    16.

    Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.

    Eliaschewitz FG, Calvo C, Valbuena H, Ruiz M, Aschner P, Villena J, Ramirez LA, Jimenez J; HOE 901/4013 LA Study Group.

    Arch Med Res. 2006 May;37(4):495-501.PMID: 16715577 [PubMed - indexed for MEDLINE]Related articles

    17.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.

    Hamann A, Matthaei S, Rosak C, Silvestre L; HOE901/4007 Study Group.

    Diabetes Care. 2003 Jun;26(6):1738-44.PMID: 12766103 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen]

    Bu S, Guo XH, Yang WY, Lu GZ, Yang ZJ, Ren TT, Gao Y.

    Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3115-8. Chinese. PMID: 18269868 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

    Clin Ther. 2008 Aug;30(8):1476-84.PMID: 18803989 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity